Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
SeraCare™ ACCURUN™ 644 Cystic Fibrosis 40plus4 Control
A synthetic, multiplex control formulated for research use in laboratory testing, molecular screening, and mutation testing
Supplier: SeraCare™ 20400015
Description
- Identifies mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene
- Covers all 47 mutations in the Prima xTAG™ CFTR IVD Assay
- Eliminate errors arising from use of rotating gDNA control schemes with incomplete mutation profiles
- Controls contain a mixture of oligonucleotides that produce a call for every mutation tested
- All mutations contained in a single vial
- High purity, large lots, stable materials–no additional processing required
Not for use in diagnostic procedures
Specifications
| CE, RUO | |
| ACCURUN 644 Cystic Fibrosis 40+4 Control | |
| Detects significant errors with the use of rotating gDNA control schemes, research use only | |
| 100 μL |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction